How digital health investors are shifting their focus in 2023

The latest stories trending on MedCity News.

Editor's Pick

Top Story How Are Digital Health Investors Shifting Their Focus In 2023? The digital health sector's quarterly investment trends seem to be stabilizing in 2023, according to a new report from Rock Health. The report noted investors are shifting their focus away from pandemic-era categories like telehealth and pharmaceutical R&D catalysts — instead, they're interested in startups creating products for disease treatment, the improvement of nonclinical workflows and the enablement of value-based care. Sponsored Content Payer's Place: Dawn Maroney, Alignment Health Presented by HLTH and MedCity News Dawn Maroney of Alignment Health highlights how they provide healthcare that helps patients be financially responsible and receive the care needed.  How the company utilizes course data and technology to help advance those needs and connect the patients with better practices and outcomes. Click here to watch the full interview!

Featured News

Hospitals Turn to Backup Power When Extreme Weather Hits Propane Generators Offer Clean Solution Propane can provide reassurance during this time of strain on the electric grid. It can keep hospitals and other critical facilities powered so that patients receive the care they need, and allow emergency responders to do their jobs effectively. Supporting Aging Populations and Their Caregivers The world is slowly aging, and by 2060, around 94.7 million older adults will be in the U.S. Without the proper care tactics in place, healthcare providers risk losing people at an earlier age and burning out family caregivers. Ounce Raises $5.2M for Housing and Care Coordination Platform Ounce's $5.2 million in seed funding was co-led by Meridian Street Capital and Flare Capital and included participation from Chelsea Clinton's Metrodora Ventures, Wilshire Lane Capital, Hilton CEO Chris Nassetta and Unite Us Co-founder Taylor Justice. Liquid Biopsy Startup Precede Sets Out to Make Precision Medicine More Precise Precede Biosciences' liquid biopsy platform yields insight into the genes and pathways in diseased tissue. Based on Dana-Farber Cancer Institute research, the startup aims to support biopharma drug R&D as it also develops the technology for clinical care applications.

Resources

MedCity Pivot Podcast: Tackling Rare Disease With Someone Who Was Touched By It Rich Horgan believes that there's an alternative path to drug development that can lower costs and the time it takes to bring drugs to market. He is trying to apply it to the field of rare and ultra-rare diseases. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe